Assiut Iniversity hospitals
Asyut, 71516, Egypt
NCT Number: NCT03070080
Fluid administration during and after surgery is an essential part of postoperative care to maintain the patients' fluid and biochemical balance. Abdominal surgical procedures are associated with dehydration from preoperative fasting, bowel preparation, and intra- and postoperative fluid and electrolyte loss. So, perioperative fluid management has been a topic of much debate over years and has intensified especially over the past several years.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Asyut, 71516, Egypt
The controversies include the type of fluid, the timing of administration and the volume administrated. Following much discussion and ongoing controversy on colloids versus crystalloids and the ideal composition of the various intravenous solutions, the main focus more recently has been on the volume of fluids.
Fluid therapy strategies have been developed and implemented in clinical practice over several decades. The data suggest that aggressive or liberal intraoperative fluid resuscitation is harmful during open abdominal operation, whereas a restrictive fluid protocol has better outcomes, including fewer postoperative complications and a shorter discharge time.
However, a restrictive fluid regimen has several limitations. Overly restricted or inadequate fluid administration may lead to insufficient intravascular volume, tissue hypoperfusion, cellular oxygenation impairment and potential organ dysfunction, prolonged recovery of bowel function, and impair tissue oxygenation, which might ultimately impair wound healing including healing of anastomosis.
Recently, the pleth-variability index (PVI) derived from respiratory variations in peripheral perfusion index (PI) has been suggested to be an effective dynamic indicator of fluid responsiveness. Different from other invasive dynamic indices, PVI provides clinicians with a numerical value obtained non-invasively. PVI is calculated as [(PI max - PI min)/PI max] X 100, where PI max and PI min represent the maximal and the minimal value, respectively, of the plethysmographic perfusion index (PI) over one respiratory cycle. PI is the ratio between pulsatile and non-pulsatile infrared light absorption from the pulse oximeter, and it is physiologically equivalent to the amplitude of the plethysmographic waveform. A PVI value of >13% before volume expansion discriminated between fluid responders and non responders with 81% sensitivity and 100% specificity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
restrictive lactated ringers as intraoperative fluid therapy in a dose of 6ml/kg/hour
Other names: fluid therapy
conservative lactated ringers as intraoperative fluid therapy in a dose of 12ml/kg/hour
Other names: conservative fluid therapy
Time frame: 24 hours postoperative
NGAL is a renal biomarker for acute kidney injury
Time frame: intraoperative
non invasive measurement of mean arterial blood pressure
Time frame: intraoperative
measurement of heart rate from pulse oximetry
Time frame: intraoperative
derived from respiratory variations in peripheral perfusion index.
Time frame: intraoperative
bradycardia defined as heart rate less than 50 beat per minute
Time frame: intraoperative
hypotension defined as systolic blood pressure less than 40% of baseline value
Assiut University
Other
Restrictive Versus Conservative Fluid Therapy in Colorectal Surgery: Hemodynamics and Kidney Function Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06206434
Dehydration, Fluid Therapy
Athens, Greece
View Trial DetailsNCT05054452
Critical Illness, Disease Attributes
Le Kremlin-Bicêtre, France
View Trial DetailsNCT07549945
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fluid Therapy
Çorum, Turkey (Türkiye)
View Trial DetailsNCT07174128
Cut-Off Value, Excision
Cairo, Egypt
View Trial Details